Answers are grounded in this paper and cite their sources.
Use of a single percutaneous silastic IV catheter for cystic fibrosis hospitalizations was evaluated among 23 patients during 45 hospitalizations. Patients ages ranged from 4 to 20 years and weights from 18 to 60 kg. Percutaneous silastic catheters were used for infusion of all IV antibiotics and IV fluids. Catheters remained in place for a total of 549 patient days (mean 12.2, range 2-34). No patient demonstrated clinical signs of local infection or sepsis. Thirty six catheters served as the single IV access for a patient's entire hospitalization. Nine catheters were removed because of discomfort, obstruction, or mechanical dysfunction before the conclusion of the hospitalization. A single, percutaneously placed silastic catheter appears to be a safe and effective way of maintaining IV access throughout the duration of hospitalization for cystic fibrosis exacerbations.
No takes yet. Share an insight, caveat, or question.
Dietrich et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: